US5936714A - Red blood cell spillover detection technique - Google Patents
Red blood cell spillover detection technique Download PDFInfo
- Publication number
- US5936714A US5936714A US09/052,277 US5227798A US5936714A US 5936714 A US5936714 A US 5936714A US 5227798 A US5227798 A US 5227798A US 5936714 A US5936714 A US 5936714A
- Authority
- US
- United States
- Prior art keywords
- passageway
- light
- blood component
- light source
- reflection intensity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000003743 erythrocyte Anatomy 0.000 title claims abstract description 41
- 230000005574 cross-species transmission Effects 0.000 title claims description 29
- 238000001514 detection method Methods 0.000 title description 11
- 239000012503 blood component Substances 0.000 claims abstract description 86
- 238000002310 reflectometry Methods 0.000 claims description 14
- 239000011888 foil Substances 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 238000012544 monitoring process Methods 0.000 claims description 6
- 230000003247 decreasing effect Effects 0.000 claims 3
- 230000004043 responsiveness Effects 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 43
- 239000008280 blood Substances 0.000 abstract description 43
- 210000001772 blood platelet Anatomy 0.000 abstract description 43
- 230000007423 decrease Effects 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 10
- 230000006870 function Effects 0.000 description 30
- 238000005534 hematocrit Methods 0.000 description 28
- 238000005259 measurement Methods 0.000 description 24
- 230000003287 optical effect Effects 0.000 description 9
- 239000000306 component Substances 0.000 description 8
- 239000004020 conductor Substances 0.000 description 8
- 238000010276 construction Methods 0.000 description 6
- 230000013011 mating Effects 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 238000012935 Averaging Methods 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000011896 sensitive detection Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 101100177155 Arabidopsis thaliana HAC1 gene Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 101100434170 Oryza sativa subsp. japonica ACR2.1 gene Proteins 0.000 description 1
- 101100434171 Oryza sativa subsp. japonica ACR2.2 gene Proteins 0.000 description 1
- 101150108015 STR6 gene Proteins 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 101100537665 Trypanosoma cruzi TOR gene Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
- G01N21/53—Scattering, i.e. diffuse reflection within a body or fluid within a flowing fluid, e.g. smoke
- G01N21/532—Scattering, i.e. diffuse reflection within a body or fluid within a flowing fluid, e.g. smoke with measurement of scattering and transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/367—Circuit parts not covered by the preceding subgroups of group A61M1/3621
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
- G01N21/3151—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using two sources of radiation of different wavelengths
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/491—Blood by separating the blood components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3622—Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
- A61M2205/331—Optical measuring means used as turbidity change detectors, e.g. for priming-blood or plasma-hemoglubine-interface detection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
- A61M2205/3313—Optical measuring means used specific wavelengths
Definitions
- the present invention generally relates to the field of blood separation, and specifically to the separation of whole human blood into its red blood cell, plasma and platelet components. More particularly, the present invention relates to the detection of an undesirable spillover of red blood cells into a blood component stream, for example a platelet stream, that should not contain red blood cells.
- Continuous blood separators are used to separate whole human blood into its various components, such as platelets, red blood cells and/or plasma. These components are removed from the separators in separate streams, sometimes referred to as collect tubes.
- the collect tubes of the blood separator are continuously monitored to detect the undesirable occurrence of a spillover of one blood component into a collect tube intended to carry a different blood component. For example, the spillover of red blood cells into a collect tube intended to carry only platelets may be monitored.
- a conventional technique by which undesirable spillover of red blood cells is monitored is the measurement of a color index of a non-red blood cell blood component that flows through a collect tube. This measurement is taken at a point downstream of the blood separator.
- a green light source By using a green light source and measuring the optical density of the non-red blood cell blood component, the total number of particles in the flowing non-red blood cell blood component and the green light absorbence of the non-red blood cell blood component can be monitored. An increase in green light absorbence in relation to optical density is then correlated to the occurrence of a red blood cell spillover.
- This type of detection equipment typically requires a light source to be physically positioned on one side of a collect tube and a photosensor located on the opposite side of the collect tube.
- the portion of the collect tube adjacent the light source must present a generally flat surface to the light source and the photosensor.
- Relatively expensive schemes and custom containers have been used to produce a flat interface to the light source and to the photosensor, to thereby increase optical efficiency in this manner.
- collect tubes may be flattened.
- U.S. Pat. No. 3,236,602 relates to a flow cell for the colorimetric examination of the light transmission characteristics of a liquid.
- U.S. Pat. No. 3,527,542 relates to apparatus for measuring blood flow wherein a first beam of monochromatic light passes through a cuvette to impinge on a first photocell while a second light beam impinges on a second photocell. The two photocell outputs are then compared.
- Reissue Pat. No. 29,141 describes a slit cell for use with optical particle sensors that operate on the principle of light scattering or interception.
- U.S. Pat. No. 4,227,814 describes an optical detector that is used with blood separating apparatus wherein red blood cell spillover is detected as a function of optical density.
- Low power light 750 foot candles at a power consumption of 1 to 2 watts
- a photodetector senses the optical density of the sample.
- Blue-green light 550 nanometers (nm) wavelength and a type 9 CAD sulfide photodetector are used.
- U.S. Pat. No. 4,229,179 describes spectrophotometric measuring apparatus wherein the visible, UV or fluorescent radiant energy that passes through a sample is detected.
- 4,444,498 describes the measurement of blood characteristics by using blood reflected light provided by two intermittently operating light sources having two different wavelengths (red and infra-red). Optical feedback loops control the intensity of the two light sources. A flat-bandwidth sensor detects the two reflections of different wavelengths.
- U.S. Pat. No. 4,810,090 describes the sensing of platelet concentration, and the detection of red blood cell spillover into the platelet flow, by using an infra-red-emitting LED (875 nm) and a green-emitting LED (565 nm) that operate at different times. These two LEDs emit light along an axis that extends through the stream of platelet flow.
- a first light sensor is placed on-axis and opposite the two light sources to detect light that passes on-axis and through the platelet stream.
- a second light sensor is placed generally across from the two light sources, but is located upstream of the first sensor, so as to measure light that is scattered off-axis and upstream of the two light sources.
- a third light sensor is placed generally across from the two light sources but is located downstream of the first sensor, to measure light that is scattered off-axis and downstream of the light sources. Under abnormal conditions, for example, when clumping, air bubbles, hemolysis, and spillovers of red blood cells or white blood cells has occurred, a color-index and a scatter-index are calculated.
- U.S. Pat. No. 4,522,494 describes an apparatus that determines the concentration of non-aggressive platelets and the concentration of discs that are within a flexible bag, using scattered laser light.
- U.S. Pat. No. 4,577,964 relates to the use of scattered light to discriminate platelets from red blood cells within a sample volume.
- U.S. Pat. No. 4,745,279 relates to the diffusion of infrared light by a volume of blood in order to measure the hematocrit of a volume of blood.
- This device may be used to measure oxygen saturation by the use of an LED light emitter and a reflection detector that are located on the same side of the blood volume.
- U.S. Pat. No. 5,372,136 describes a finger-clip/ear-lobe-clip arrangement in which at least two wavelengths of light are passed through body tissue and light transmission or reflection is detected by a photodetector.
- the present invention provides a new, unusual and unobvious construction and arrangement for monitoring the undesirable spillover of a blood component in a tube intended to carry a different blood component.
- the present invention is particularly adapted for continuously monitoring one or more blood collect tubes at one or more locations downstream of a continuous blood separator, to detect the undesirable spillover of one blood component into a collect tube intended to carry a different blood component.
- the undesirable spillover of red blood cells into a tube intended to carry platelets is continuously monitored.
- the present invention provides two light sources having two different but related emission wavelengths.
- the light outputs of these two light sources are directed toward a tube intended to exclusively carry a first blood component.
- the two different light wavelengths are selected such that (1) the first light source has a first wavelength which is reflected from a second blood component with an intensity that increases with an increase in the concentration of the second blood component, and (2) the second light source has a second wavelength which is reflected from the second blood component with an intensity that decreases as a function of an increase in the concentration of the second blood component.
- the intensity of the first light source's reflection and the intensity of the second light source's reflection are both detected. This results in an intensity-1 electrical signal that increases when the second blood component concentration or density increases, and an intensity-2 electrical signal that decreases when the second blood component concentration or density increases.
- an arrangement is provided which is very sensitive to the occurrence of a spillover of the second blood component into the tube intended to carry only the first blood component.
- this comparison comprises a ratio measurement wherein the numerator increases and the denominator decreases as the concentration of red blood cells increases.
- the second blood component comprises red blood cells
- the first light source is a red light source
- the second light source is a green light source
- the electrical comparison operates to detect the ratio of the reflected red light intensity to the reflected green light intensity. Since an increase in the concentration of red blood cells causes the numerator of this ratio to increase, as the denominator of this ratio concomitantly decreases, the resulting ratio signal is very sensitive to changes in the concentration of red blood cells within the tube. For example, this ratio changes markedly at hematocrit of 1%, 0.5% and even below 0.5%, thus making the apparatus/method of this invention more sensitive than prior detection of red blood cell spillover.
- the light outputs of these two light sources may be continuous, in which case the two light reflections are simultaneously detected by the use of two light specific detectors that are individually responsive only to one of the two wavelengths.
- the two light sources are pulse-energized during two different time intervals, and one or two light detectors are provided, having a relatively wide wavelength response. Since the two light reflections occur during two different time intervals, interference between the two light reflections is prevented.
- the second blood component includes another particular component
- reflection of the green and red light from that particular component is found to be affected in a similar manner as the concentration or density of the component changes.
- each light source and its mating light detector are physically mounted on the same side of the tube.
- the two light sources and the two detectors are physically located on the same side of the tube.
- the tube can be automatically loaded into the apparatus of this invention, and set-up time and manufacturing cost are minimized.
- the construction and arrangement of this invention does not require the use of cuvettes, does not require that the tube be flattened, is less prone to the false detection of red blood cell spillover, locates the light emitters and the light detectors on the same side of the tube, and provides for the optically efficient and sensitive detection of red blood cell spillover.
- FIG. 1 is a schematic representation of a continuous blood separator having three relatively transparent blood component collect tubes and a red blood cell detector in accordance with the present invention associated with one of the collect tubes.
- FIG. 2 is a flowchart illustrating the method of the present invention.
- FIG. 3 shows an embodiment of the invention wherein a platelet collect tube has associated therewith a first emit/detect station that operates to emit a first color of light (red) into the collect tube, and then to detect the reflection of this first color from the blood component flow within collect tube, and a second emit/detect station that operates to emit a second color of light (green) into the collect tube, and then to detect the reflection of this second color from the blood component flow within the collect tube.
- a first emit/detect station that operates to emit a first color of light (red) into the collect tube, and then to detect the reflection of this first color from the blood component flow within collect tube
- a second emit/detect station that operates to emit a second color of light (green) into the collect tube, and then to detect the reflection of this second color from the blood component flow within the collect tube.
- FIG. 4 shows an embodiment of the invention wherein a platelet collect tube has associated therewith a first emit/detect station that operates to emit a first color of light (red) into the collect tube, and to then detect the reflection of this first color from the blood component flow within the collect tube, wherein a second emit/detect station is located diametrically across from the first emit/detect station and is operative to emit a second color of light (green) into the collect tube, and then to detect the reflection of this second color from the blood component flow within the collect tube.
- a first emit/detect station that operates to emit a first color of light (red) into the collect tube, and to then detect the reflection of this first color from the blood component flow within the collect tube
- a second emit/detect station is located diametrically across from the first emit/detect station and is operative to emit a second color of light (green) into the collect tube, and then to detect the reflection of this second color from the blood component flow within the collect tube.
- FIG. 5 shows a preferred embodiment of the invention wherein blood component flow takes place perpendicular to the plane of the figure, wherein red light and green light are projected at an angle of about 45 degrees to the collect tube-axis of a collect tube, and wherein a single photodetector views the collect tube along an angle generally 90 degrees to the collect tube-axis.
- FIG. 6 is a flowchart showing of an initializing procedure for the apparatus of FIG. 5.
- FIG. 7 is a graph which contains a multiplicity of curves each of which represent changes in light reflection measured at wavelengths of from 400 to 700 nm incident upon a blood sample from a donor having a relatively high concentration of platelets, wherein the hematocrit of the samples range from a zero hematocrit (Series 1) to 3% hematocrit (Series 5).
- FIG. 8 is a graph which contains a multiplicity of curves similar to that of FIG. 7, in which the blood sample is from a donor having a normal concentration of platelets.
- FIG. 9 is a graph which contains a multiplicity of curves similar to that of FIGS. 7 and 8, in which the blood sample is from a donor having a relatively low concentration of platelets.
- FIG. 10 is a plan view of an embodiment of a cassette having a blood component flow passageway with which the techniques of the present invention may be practiced.
- FIG. 11 is a vertical section of the component flow passageway shown in FIG. 10.
- conventional continuous blood separator 20 includes three relatively transparent blood component collect tubes 21, 22 and 23.
- Collect tube 21 is intended to carry red blood cells.
- Platelet collect tube 22 is intended to carry platelets, with the flow rate of the blood component within collect tube 22 typically in the range of from about 0.8 to about 25 ml/min.
- Plasma collect tube 23 is intended to carry blood plasma.
- collect tubes 21, 22 and 23 are constructed of optically transparent polyvinylchloride and are generally circular in cross section, and having an inner diameter of about 2.87 mm and an outer diameter of about 4.75 mm.
- a red blood cell spillover detector 24 of the present invention is associated with collect tube 22. While the physical spacing or distance that exists between detector 24 and separator 20 is not critical, a utility of the present invention includes halting separator 20 when red blood cells are detected in platelet collect tube 22. Therefore, it may be desirable to keep the physical separation between detector 24 and separator 20 at a minimum.
- the detector 24 includes light sources and mating light detector(s). In accordance with an important feature of the invention, both light sources and the mating light detector(s) that are within detector 24 are located on the same side of collect tube 22.
- FIG. 2 is a flowchart illustrating the present invention.
- red light and green light are directed toward the blood collect tube that is to be monitored for the presence or spillover of red blood cells.
- green light is intended to mean visible electromagnetic radiation having a wavelength of from about 4,912 to about 5,750 angstroms
- red light is intended to mean visible electromagnetic radiation having a wavelength of from about 6,470 to about 7,000 angstroms.
- Functions/method steps 10, 11 can occur during the same time interval, in which case two light sensors or light detectors are provided, one sensor being selectively responsive only to red light reflection and the other sensor being selectively responsive only to green light reflection.
- the two steps 10, 11 occur during two different but closely spaced time intervals.
- only one sensor may be provided, this one sensor having a wide wavelength response so that it is responsive to red light reflection during one time interval, and is responsive to green light reflection during another time interval.
- the detection of red light reflection and green light reflection are shown at functions 12 and 13, respectively.
- FIG. 2 shows a compare function 15 that compares the ratio that was determined by function 14 to a user supplied threshold value 16, which is the minimum spillover tolerated or lacking in adverse consequences for a given application.
- a function 17 then responds to comparison 15, and provides an output when the ratio output of 14 exceeds the threshold output of 16.
- FIG. 3 shows an embodiment of the invention wherein platelet collect tube 22 has associated therewith a first emit/detect station 30 in accordance with the invention that operates to emit a first color of light (red) into collect tube 22, and then to detect the reflection of this first color from the blood component flow 32 within collect tube 22.
- a second emit/detect station 31 Spaced a short distance from station 30 is a second emit/detect station 31 in accordance with the invention that operates to emit a second color of light (green) into collect tube 22, and then to detect the reflection of this second color from the blood component flow 32 within collect tube 22.
- both the light source and its mating light detector are located on the same side of collect tube 22.
- the two respective output conductors 34 and 35 of stations 30 and 31 carry electrical signals whose magnitudes are directly proportional to the magnitude of the reflected first light and to the magnitude of the reflected second light.
- An electrical signal comparator 33 in accordance with the invention operates to compare the two signals on conductors 34, 35, and to provide an output 34 as a result of this comparison.
- the two stations 30, 31 may operate during the same time interval having a duration of, for example, fractions of a second. In this case the two signals on conductors 34 and 35 also appear during this common time interval.
- Signal comparator 33 may or may not include a latch means (not shown) that operates to latch the magnitudes of these two signals 34, 35 to enable a magnitude comparison to be made.
- the above described signal comparison is a comparison, such as a ratio calculation, that takes advantage of the fact that red light reflection increases and green light reflection decreases as the concentration of red blood cells increases.
- the two stations 30, 31 may also operate during two different time intervals that are spaced from one another.
- the two signals on conductors 34 and 35 also appear during these two different time intervals, and signal comparator includes a latch means (not shown) that operates to latch the magnitudes of these two signals 34, 35 in order to enable a magnitude comparison to be made after expiration of the later or second of the two time intervals.
- FIG. 4 shows an embodiment of the invention wherein platelet collect tube 22 has associated therewith a first emit/detect station 40 in accordance with the invention that operates to emit a first color of light (red) into collect tube 22, and to then detect the reflection of this first color from the blood component flow 32 within collect tube 22.
- a second emit/detect station 41 Located diametrically across from station 40 is a second emit/detect station 41 in accordance with the invention that operates to emit a second color of light (green) into collect tube 22, and then to detect the reflection of this second color from the blood component flow 32 within collect tube 22.
- Two respective output conductors 44 and 45 of stations 40 and 41 carry electrical signals whose magnitudes are directly proportional to the magnitude of the reflected first light and to the magnitude of the reflected second light.
- An electrical signal comparator 33 in accordance with the invention operates to compare the two signals on conductors 44, 45, and to provide an output 34 as a result of this comparison.
- the two stations 40, 41 may operate during the same time interval, whereupon the two stations 40, 41 include individual light detectors that are selectively responsive only to the first light for the detector of station 40, and to the second light for the detector of station 41. In this case, the two signals on conductors 44 and 45 also appear during this time common interval. Comparator 33 may or may not include a latch means (now shown) to latch the magnitudes of these two signals 44, 45 as the signal comparison is made.
- the two stations 40, 41 may also operate during two different time intervals. In this case, the light detector that is within each of the two stations 40, 41 is rendered operative only during the period of operation of that respective station 40, 41.
- the two light detectors may be of a relatively wide color response.
- the two electrical signals on conductors 44 and 45 also appear during these two different time intervals, and signal comparator 33 in this case includes a latch means (not shown) that operates to latch the magnitudes of these two signals 44, 45 in order to enable a comparison to be made after expiration of the later or second time interval.
- each individual light source and its mating light detector are located on the same side of collect tube 22.
- the signal comparison provided at 33 is a comparison, such as a ratio calculation, that takes advantage of the fact that red light reflection increases and green light reflection decreases as the concentration of red blood cells increases.
- FIG. 5 shows a preferred embodiment of the invention wherein blood component flow takes place through a three dimensional volume 50 that is defined by the intersection of a red-light beam 52 and a green-light beam 51.
- the direction of blood component flow relative to the plane of FIG. 5 is not critical. For example, flow may be perpendicular to the plane of FIG. 5, flow may be in the plane of FIG. 5, or flow may take place at an angle to the plane of FIG. 5. That is, area 50 represents a generally spherical volume that carries the blood component flow to be monitored, for example this flow may take place within a circular cross section, visually transparent, collect tube as previously described.
- the two linear, rod-shaped beams 51 and 52 of FIG. 5 generally designate a beam of green light that is emitted from a green LED 53, and a beam of red light 52 that is emitted from a red LED 54.
- Beams 51, 52 are, for example, circular in cross section.
- light beams 51, 52 are directed at an angle of about 45 degrees to a horizontal reference axis 55 that extends in the plane of FIG. 5, i.e. beams 51, 52 define an included angle 58 of about 90 degrees.
- a photosensor 56 that is responsive to both green light reflection and red light reflection is positioned to view volume 50 and the red light and green light that is reflected therefrom. This reflection takes place along a photosensor view axis 59 that extends downward at about 90 degrees to reference axis 55, i.e. photosensor view axis 59 generally bisects angle 58. While not critical to the invention, sensor 56 comprises a photodiode, having a size of about 2.92 mm.
- LEDs 53, 54 and photosensor 56 are all located in a common plane that includes volume 50, i.e., for example, they may be located in the plane of FIG. 5, or they may be located in a common plane that is inclined to the plane of FIG. 5. In any case, as will be appreciated, the detailed construction and arrangement of FIG. 5 provides a number of mechanical or physical support surfaces and the like. In operation, photosensor 56 operates to detect red light and green light that is reflected off of these various surfaces as well as from the blood components that are flowing through volume 50.
- LEDs 53, 54 are pulsed off and then on at the rate of about 2 Khz, with a generally equal off/on duty cycle.
- This pulse energization of LEDs 53, 54 is time-staggered such that one LED is on during the time interval that the other LED is off.
- the two output signals that are provided by photosensor 56 i.e. a red light reflection output during one time interval, and a green light reflection output during a second time interval, are now processed by a signal comparator such as 33 of FIGS. 3 and 4, in accordance with FIG. 2.
- a signal comparator such as 33 of FIGS. 3 and 4, in accordance with FIG. 2.
- the hematocrit is about 1 percent when this ratio equals about 1.5.
- a dry, empty cassette is positioned in a red blood cell spillover detector 24 in which LEDs 53 and 54 are off.
- the blood separation system 20 of which the detector 24 is a part immediately and automatically detects the presence of an empty cassette (function 61) and is programmed to immediately proceed to perform a series of operations to adjust a compensated red/compensated green ratio to 1 prior to introduction of blood into the cassette.
- the red LED 53 is energized for eight cycles with an LED which functions at 2000 cycles/second, as shown at function 62.
- red LED 53 is de-energized (function 64), during which time two sample measurements are taken and designated reflected red light off values, as shown at function 65.
- the functions 62, 63, 64 and 65 are repeated seven more times, that is, until sixteen reflected red light on measurements are collected and sixteen reflected red light off measurements are collected.
- the average reflected red light is determined by averaging the sixteen reflected red light on measurements, averaging the sixteen eight reflected red light off measurements, and subtracting the average reflected red light off from the average reflected red light on, as shown at function 66.
- the green LED 54 is then energized for eight cycles with an LED which also functions at 2000 cycles/second, as shown at function 67.
- an LED which also functions at 2000 cycles/second, as shown at function 67.
- two sample measurements are taken and stored, and represent reflected green light on values, as shown at function 68.
- green LED 54 is deenergized (function 69), during which time two sample measurements are taken and designated reflected green light off values, as shown at function 70.
- the functions 67, 68, 69 and 70 are repeated seven more times, that is, until sixteen reflected green light on measurements are collected and sixteen reflected green light off measurements are collected.
- the average reflected green light is determined by averaging the sixteen reflected green light on measurements, averaging the sixteen reflected green light off measurements, and subtracting the average reflected green light off from the average reflected green light on (function 71).
- the FIG. 6 initializing procedure is completed at function 72 by setting the calculated red/green ratio to be equal to the value "one", which may be accomplished by adjusting the energizing current to the green LEDs 54. If a value of "one" cannot be achieved with such an adjustment, the system is placed in an alarm condition. Note that it is not critical to the invention whether the average reflected red light is determined (steps 62-66) before or after the average reflected green light is determined (steps 67-71). In addition, it should be understood that before step 72 is performed and the compensated red/compensated green ratio is set to one, as described above, multiple repetitions of steps 62-71 may be performed, thereby providing additional data for the average reflected light values and the red/green ratio. Furthermore, it should also be understood that while in the presently preferred embodiment, a specific number of measurements and cycle frequencies are disclosed, the number, frequency, and pattern of measurements and cycles may be varied.
- Blood then is introduced into the cassette, and as it flows therethrough, reflected red light and reflected green light are repeatedly measured as described in steps 62-71. After each pair of average reflected red light and reflected green light values are obtained (steps 66 and 71), a ratio of reflected red to reflected green is obtained. If the ratio of reflected red to reflected green reaches or exceeds predetermined limits, than a spillover condition is indicated.
- FIG. 7 changes in reflection of light of wavelengths of from 400 to 700 nm incident upon a blood sample from a donor having a relatively high concentration of platelets are plotted.
- the blood sample tested in Series 1 had a zero hematocrit (hct)
- the sample tested in Series 2 had a 0.1% hct
- the sample tested in Series 3 had a 0.5% hct
- the sample tested in Series 4 had a 1% hct
- the sample tested in Series 5 had a 3% hct.
- Table I The approximate ratios of reflected red light of approximately 700 nm to reflected green light of approximately 550 nm from FIG. 7 are summarized in Table I.
- the measurement of a sample of plasma flowing through a passageway of a cassette in which there are no platelets present is first measured, with reflectivity baselines set for both red and green wavelengths. Known concentrations of platelets are then allowed to flow through the passageway. Reflectivity of red and green wavelengths are again measured, and the red and green reflectivities compared to the baseline values. The two ratios thereby obtained are then averaged, and represent the "detector outputs". It can be seen in Table IV that the decrease in detector output ratios is a function of the increase in platelet concentration, which indicates that concentration of a blood component such as platelets may be monitored.
- polyester cassettes such cassette 80 shown in FIG. 10 were used to evaluate blood samples using the technique of the present invention.
- the polyester cassettes were treated with a hot stamp foil rectangle 81 approximately 1/2" by 1" of one of three colors--black, gray (foil No. LT12106) and white (No. CC11206). Reflectivity of green and red light as described above was measured on blood samples having differing hematocrit values. The results are summarized below in Table V.
- a review of the data shown in Table V indicates how the empty cassettes marked with selected black, gray and white foil have distinguishing reflectivity.
- This varying reflectivity may be used, for example, to indicate the identity of the blood component expected to pass through the portion of the cassette adjacent the photosensor, the nature of the disposable set mounted to the blood separator, or may be indicative of the blood components to be collected, or both. Accordingly, that portion of the cassette which comprises a foil, a color-coded surface or other surface of varying reflectivity having a predetermined and distinguishing reflectivity constitutes an identification portion of the cassette.
- the data shown in Table V also appears to indicate that regardless of the presence of the foils identified above and attached to the cassettes tested, there remains a trend of increasing ratio of red reflectivity to green reflectivity in blood samples, as hematocrit increases in the blood samples.
- tubing set which includes tubing 82, 83, 84, 85, 86, 87, 88, 89, 90 and 91.
- flowing through tubing 90 is a first blood component, for example, platelets.
- Tubing 90 has a preferred diameter of 0.035 inches and is in fluid communication with a passageway 92 which, in turn, is in fluid communication with tubing 91.
- Tubing 91 is in fluid communication with a collection container (not shown).
- Passageway 92 includes an input passageway 93 having a preferred rectangular cross section of 0.040 inches by 0.040 inches, and thus a cross sectional area of approximately 0.0016 square inches.
- an exit passageway 94 also having a preferred rectangular cross section of 0.040 inches by 0.040 inches, and thus a cross sectional area of approximately 0.0016 square inches.
- Central chamber 95 includes an upwardly sloped upper wall 96 above a widened portion 97 and an upwardly sloped lower wall 98. Referring now to FIG. 11, it can be seen that central chamber 95 is rectangular in cross section, with a preferred width of 0.060 inches, a preferred height of 0.200 inches, and thus a preferred cross sectional area of 0.012 square inches.
- the upwardly sloping wall 96 prevents entrapment in the passageway 92 of any bubbles which might otherwise be present in the blood component flowing in passageway 92, thus providing for more accurate measurements.
- the upwardly sloping lower wall 98 prevents heavier materials in the blood component flowing in passageway 92 from being entrapped in passageway 92.
- the enlarged cross sectional area of central chamber 95 as compared to input passageway 93 promotes adequate mixing of the blood component flowing in passageway 92 and allows a cross sectional area sufficient for measurement of reflectively by the photosensor apparatus, thus increasing accuracy and sensitivity of the spillover detection technique of the present invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Hematology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Ecology (AREA)
- Anesthesiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- External Artificial Organs (AREA)
Abstract
Description
TABLE I ______________________________________SERIES HEMATOCRIT 1 #STR1## RATIO ______________________________________ 1 0% 2 #STR2## 0.9 2 0.1% 3 #STR3## 1.1 3 0.5% 4 #STR4## 1.5 4 1% 5 #STR5## 1.7 5 3% 6 #STR6## 2.0 ______________________________________
TABLE II ______________________________________SERIES HEMATOCRIT 1 #STR7## RATIO ______________________________________ 1 0% 7 #STR8## 1.0 2 0.1% 8 #STR9## 1.2 3 0.5% 9 #STR10## 1.5 4 1% 0 #STR11## 1.7 5 3% 1 #STR12## 2.1 ______________________________________
TABLE III ______________________________________SERIES HEMATOCRIT 1 #STR13## RATIO ______________________________________ 1 0% 2 #STR14## 1.0 2 0.1% 3 #STR15## 1.1 3 0.5% 4 #STR16## 1.4 4 1% 5 #STR17## 1.7 5 3% 6 #STR18## 2.0 ______________________________________
TABLE IV ______________________________________ Platelet Detector Detector Detector Detector concentration output output output output (platelets/μl) (Set 1) (Set 2) (Set 1) (Set 2) ______________________________________ 3580 0.756 0.702 0.676 2609 0.782 0742 0.713 0.712 1531 0.840 0.816 0.782 864 0.878 0.880 0.835 0.843 0 1 1 1 1 ______________________________________
TABLE V ______________________________________ 1 #STR19## RATIO w/black w/gray w/white w/black w/gray w/white HEMATO- back- back- back- back- back- back- CRIT ground ground ground ground ground ground ______________________________________ nocassette 7 #STR20##empty cassette 8 #STR21## 9 #STR22## 0 #STR23## 0% 1 #STR24## 2 #STR25## 3 #STR26## 2.2 2.2 1.1 0.5% 4 #STR27## 5 #STR28## 6 #STR29## 3.3 4.0 1.5 1% 7 #STR30## 8 #STR31## 9 #STR32## 4.6 4.6 2.0 2% 0 #STR33## 1 #STR34## 2 #STR35## 6.4 5.9 2.3 3% 3 #STR36## 4 #STR37## 5 #STR38## 6.4 6.5 2.5 ______________________________________
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/052,277 US5936714A (en) | 1996-11-06 | 1998-03-30 | Red blood cell spillover detection technique |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/746,109 US5734464A (en) | 1996-11-06 | 1996-11-06 | Red blood cell spillover detection technique |
US09/052,277 US5936714A (en) | 1996-11-06 | 1998-03-30 | Red blood cell spillover detection technique |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/746,109 Continuation-In-Part US5734464A (en) | 1996-11-06 | 1996-11-06 | Red blood cell spillover detection technique |
Publications (1)
Publication Number | Publication Date |
---|---|
US5936714A true US5936714A (en) | 1999-08-10 |
Family
ID=24999526
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/746,109 Expired - Lifetime US5734464A (en) | 1996-11-06 | 1996-11-06 | Red blood cell spillover detection technique |
US09/052,277 Expired - Lifetime US5936714A (en) | 1996-11-06 | 1998-03-30 | Red blood cell spillover detection technique |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/746,109 Expired - Lifetime US5734464A (en) | 1996-11-06 | 1996-11-06 | Red blood cell spillover detection technique |
Country Status (5)
Country | Link |
---|---|
US (2) | US5734464A (en) |
EP (1) | EP0904537B1 (en) |
JP (1) | JP3698732B2 (en) |
DE (1) | DE69733198T2 (en) |
WO (1) | WO1998020345A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6130743A (en) * | 1999-06-28 | 2000-10-10 | The United States Of America As Represented By The Secretary Of The Navy | Colorimetric red blood cell sensor |
EP1106991A2 (en) * | 1999-12-01 | 2001-06-13 | Fresenius HemoCare GmbH | Method and apparatus for determining particle concentration |
US20050054508A1 (en) * | 2003-09-05 | 2005-03-10 | Ivo Panzani | Control device for the separate collection of blood components in output from a blood centrifugation cell |
EP1605251A1 (en) * | 2004-06-09 | 2005-12-14 | Tyco Electronics Raychem GmbH | Gas sensor arrangement with reduced settling time |
US20060021952A1 (en) * | 2003-09-11 | 2006-02-02 | Skinkle David W | Apparatus for separating blood components |
US20070178013A1 (en) * | 2005-07-26 | 2007-08-02 | Kalonia Devendra S | Dual-detector systems and methods having utility in biomolecular measurements |
US20090166297A1 (en) * | 2007-12-27 | 2009-07-02 | Caridianbct, Inc. | Blood Processing Apparatus with Controlled Cell Capture Chamber Trigger |
US20100065507A1 (en) * | 2008-09-18 | 2010-03-18 | Caridianbct, Inc. | Blood Processing Apparatus with Optical Reference Control |
US20100231893A1 (en) * | 2009-03-10 | 2010-09-16 | Spectra Tracker LLC | Method and device for spectrally detecting hemoglobin |
US20100267538A1 (en) * | 2009-04-15 | 2010-10-21 | Caridianbct, Inc. | Methods and Apparatus for Hemolysis Detection in Centrifugal Blood Separator |
US20110082452A1 (en) * | 2009-10-02 | 2011-04-07 | Cardiofocus, Inc. | Cardiac ablation system with automatic safety shut-off feature |
US11666693B2 (en) * | 2016-09-06 | 2023-06-06 | Fresenius Kabi Deutschland | Automated method for leukocyte collection from whole blood |
EP4368219A1 (en) * | 2022-11-08 | 2024-05-15 | Haermonics BV | System for flushing a wound and/or a body cavity, in particular the pericardial cavity |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19530969A1 (en) * | 1995-08-23 | 1997-02-27 | Deutsches Rotes Kreuz Blutspen | Device for the flow separation of whole blood as a mixture of liquids into individual blood components of different colors, in particular for the separation of platelet concentrate from buffy coat |
US5734464A (en) * | 1996-11-06 | 1998-03-31 | Cobe Laboratories, Inc. | Red blood cell spillover detection technique |
US6175420B1 (en) | 1998-05-20 | 2001-01-16 | Zymequest, Inc. | Optical sensors for cell processing systems |
US6144444A (en) * | 1998-11-06 | 2000-11-07 | Medtronic Avecor Cardiovascular, Inc. | Apparatus and method to determine blood parameters |
US6877713B1 (en) | 1999-07-20 | 2005-04-12 | Deka Products Limited Partnership | Tube occluder and method for occluding collapsible tubes |
JP2005509412A (en) | 2001-08-23 | 2005-04-14 | アールエスアール リミテッド | Antigenic region of thyrotrophin (TSH) receptor, use thereof and antibody thereof |
DE102007000309A1 (en) * | 2007-06-05 | 2008-12-11 | Andreas Hettich Gmbh & Co. Kg | Method for cell recovery |
DE102007000310A1 (en) * | 2007-06-05 | 2008-12-18 | Andreas Hettich Gmbh & Co. Kg | Insert and centrifuge with insert |
DE102007000308A1 (en) * | 2007-06-05 | 2008-12-18 | Andreas Hettich Gmbh & Co. Kg | Insert and centrifuge with insert |
US9078971B2 (en) | 2008-01-23 | 2015-07-14 | Deka Products Limited Partnership | Medical treatment system and methods using a plurality of fluid lines |
WO2009094182A2 (en) | 2008-01-23 | 2009-07-30 | Deka Products Limited Partnership | Pump cassette and methods for use in medical treatment system using a plurality of fluid lines |
PT2265944E (en) * | 2008-04-04 | 2015-09-23 | Medical Vision Ab | Measurement of particles in liquid using reflected light |
US20110105877A1 (en) * | 2009-10-30 | 2011-05-05 | Deka Products Limited Partnership | Apparatus and method for detecting disconnection of an intravascular access device |
DE102010000752A1 (en) | 2010-01-08 | 2011-07-14 | Andreas Hettich GmbH & Co. KG, 78532 | Cassette and system part which can be used in cooperation with the cassette in a centrifuge |
DE102010000753A1 (en) | 2010-01-08 | 2011-07-14 | Andreas Hettich GmbH & Co. KG, 78532 | Cassette and system part which can be used in cooperation with the cassette in a centrifuge |
JP5579479B2 (en) * | 2010-03-30 | 2014-08-27 | シスメックス株式会社 | Sample analyzer |
CA2804216C (en) | 2010-07-07 | 2019-01-15 | Deka Products Limited Partnership | Medical treatment system and methods using a plurality of fluid lines |
SG10201800720YA (en) | 2011-05-24 | 2018-03-28 | Deka Products Lp | Blood treatment systems and methods |
US9999717B2 (en) | 2011-05-24 | 2018-06-19 | Deka Products Limited Partnership | Systems and methods for detecting vascular access disconnection |
CA2844807C (en) | 2011-08-19 | 2022-07-26 | Hospira, Inc. | Systems and methods for a graphical interface including a graphical representation of medical data |
WO2013067359A2 (en) | 2011-11-04 | 2013-05-10 | Deka Products Limited Partnership | Medical treatment system and methods using a plurality of fluid lines |
EP3398627B1 (en) | 2011-12-07 | 2023-02-01 | Terumo BCT, Inc. | Apparatus for donor platelet pre-count in centrifugal blood separator |
WO2013148798A1 (en) | 2012-03-30 | 2013-10-03 | Hospira, Inc. | Air detection system and method for detecting air in a pump of an infusion system |
US9164078B2 (en) * | 2012-06-15 | 2015-10-20 | Fenwal, Inc. | Process for predicting hematocrit of whole blood using IR light |
AU2013296555B2 (en) | 2012-07-31 | 2017-10-19 | Icu Medical, Inc. | Patient care system for critical medications |
EP2994042B1 (en) | 2013-05-10 | 2023-09-27 | University Of Utah Research Foundation | Devices, systems, and methods for measuring blood loss |
US10690684B2 (en) | 2013-05-10 | 2020-06-23 | Majelco Medical, Inc. | Apparatus and system for measuring volume of blood loss |
US10046112B2 (en) | 2013-05-24 | 2018-08-14 | Icu Medical, Inc. | Multi-sensor infusion system for detecting air or an occlusion in the infusion system |
WO2014194065A1 (en) | 2013-05-29 | 2014-12-04 | Hospira, Inc. | Infusion system and method of use which prevents over-saturation of an analog-to-digital converter |
JP2015039542A (en) | 2013-08-22 | 2015-03-02 | セイコーエプソン株式会社 | Pulse wave measuring device |
EP3068542B1 (en) * | 2013-11-15 | 2023-08-09 | Terumo BCT, Inc. | Method and apparatus for controlling flow of components separated from whole blood |
JP6636442B2 (en) | 2014-02-28 | 2020-01-29 | アイシーユー・メディカル・インコーポレーテッド | Infusion systems and methods utilizing dual wavelength optical in-pipe air detection |
US10850024B2 (en) | 2015-03-02 | 2020-12-01 | Icu Medical, Inc. | Infusion system, device, and method having advanced infusion features |
WO2017152285A1 (en) | 2016-03-09 | 2017-09-14 | Lab Improvements | Apparatus and method for indicating at least one property related to an object |
WO2017180656A1 (en) | 2016-04-11 | 2017-10-19 | Alfred Akerman | Apparatus and system for measuring volume of blood loss |
WO2017197024A1 (en) | 2016-05-13 | 2017-11-16 | Icu Medical, Inc. | Infusion pump system and method with common line auto flush |
WO2017214441A1 (en) | 2016-06-10 | 2017-12-14 | Icu Medical, Inc. | Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion |
US11478792B2 (en) | 2016-10-03 | 2022-10-25 | Terumo Bct, Inc. | Centrifugal fluid separation device |
US10089055B1 (en) | 2017-12-27 | 2018-10-02 | Icu Medical, Inc. | Synchronized display of screen content on networked devices |
CN110639077B (en) * | 2019-10-25 | 2024-11-15 | 重庆山外山血液净化技术股份有限公司 | Blood leakage monitoring device and monitoring method for continuous blood purification equipment |
AU2021311443A1 (en) | 2020-07-21 | 2023-03-09 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
EP4011414A1 (en) * | 2020-12-10 | 2022-06-15 | Fresenius Kabi Deutschland GmbH | System for blood cell separation |
CN113533244A (en) * | 2021-06-18 | 2021-10-22 | 中国科学院深圳先进技术研究院 | A detection method, device, terminal and readable storage medium for hematocrit |
Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3236602A (en) * | 1962-05-03 | 1966-02-22 | Technicon Instr | Colorimeter flow cell and holder therefor |
US3527542A (en) * | 1966-06-15 | 1970-09-08 | Beckman Instruments Inc | Cardiac output apparatus |
US3751173A (en) * | 1972-08-24 | 1973-08-07 | Micromedic Systems Inc | Flowthrough cuvette |
USRE29141E (en) * | 1973-06-14 | 1977-02-22 | Coulter Electronics, Inc. | Apparatus for orienting generally flat particles for sensing |
US4227814A (en) * | 1979-02-01 | 1980-10-14 | Baxter Travenol Laboratories, Inc. | Optical density detector |
US4229179A (en) * | 1978-06-30 | 1980-10-21 | Hycel, Inc. | Spectrophotometric measurement in a chemical testing apparatus |
US4444498A (en) * | 1981-02-27 | 1984-04-24 | Bentley Laboratories | Apparatus and method for measuring blood oxygen saturation |
US4522494A (en) * | 1982-07-07 | 1985-06-11 | The United States Of America As Represented By The Department Of Health And Human Services | Non-invasive optical assessment of platelet viability |
US4577964A (en) * | 1978-09-06 | 1986-03-25 | Ortho Diagnostics, Inc. | Apparatus and method for detecting platelets in whole blood |
US4745279A (en) * | 1986-01-02 | 1988-05-17 | American Hospital Supply Corporation | Hematocrit measuring apparatus |
US4810090A (en) * | 1987-08-24 | 1989-03-07 | Cobe Laboratories, Inc. | Method and apparatus for monitoring blood components |
US4834890A (en) * | 1987-01-30 | 1989-05-30 | Baxter International Inc. | Centrifugation pheresis system |
US5047652A (en) * | 1990-04-16 | 1991-09-10 | International Paper Company | System for on-line measurement of color, opacity and reflectance of a translucent moving web |
US5141303A (en) * | 1989-05-08 | 1992-08-25 | Kowa Company Ltd. | Method and apparatus for discriminating eye fundus blood vessels |
US5372136A (en) * | 1990-10-06 | 1994-12-13 | Noninvasive Medical Technology Corporation | System and method for noninvasive hematocrit monitoring |
US5437598A (en) * | 1994-01-21 | 1995-08-01 | Cobe Laboratories, Inc. | Automation of plasma sequestration |
US5653887A (en) * | 1995-06-07 | 1997-08-05 | Cobe Laboratories, Inc. | Apheresis blood processing method using pictorial displays |
US5734464A (en) * | 1996-11-06 | 1998-03-31 | Cobe Laboratories, Inc. | Red blood cell spillover detection technique |
US5769811A (en) * | 1995-10-31 | 1998-06-23 | Haemonetics Corporation | Blood-processing machine system |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4017190A (en) * | 1975-07-18 | 1977-04-12 | Halbert Fischel | Blood leak detector comparing intensities of high absorption band and low absorption band of a single beam of light passing through a sample |
US4350441A (en) * | 1980-06-30 | 1982-09-21 | Baxter Travenol Laboratories, Inc. | Photometric apparatus and method |
JPS62838A (en) * | 1985-06-26 | 1987-01-06 | Kawasumi Lab Inc | Hemolysis measuring instrument |
JPS6324143A (en) * | 1986-11-20 | 1988-02-01 | Terumo Corp | Instrument and method for measuring hemoglobin concentration |
US5291884A (en) * | 1991-02-07 | 1994-03-08 | Minnesota Mining And Manufacturing Company | Apparatus for measuring a blood parameter |
-
1996
- 1996-11-06 US US08/746,109 patent/US5734464A/en not_active Expired - Lifetime
-
1997
- 1997-11-04 EP EP97947349A patent/EP0904537B1/en not_active Expired - Lifetime
- 1997-11-04 JP JP52171198A patent/JP3698732B2/en not_active Expired - Fee Related
- 1997-11-04 WO PCT/US1997/020086 patent/WO1998020345A1/en active IP Right Grant
- 1997-11-04 DE DE69733198T patent/DE69733198T2/en not_active Expired - Lifetime
-
1998
- 1998-03-30 US US09/052,277 patent/US5936714A/en not_active Expired - Lifetime
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3236602A (en) * | 1962-05-03 | 1966-02-22 | Technicon Instr | Colorimeter flow cell and holder therefor |
US3527542A (en) * | 1966-06-15 | 1970-09-08 | Beckman Instruments Inc | Cardiac output apparatus |
US3751173A (en) * | 1972-08-24 | 1973-08-07 | Micromedic Systems Inc | Flowthrough cuvette |
USRE29141E (en) * | 1973-06-14 | 1977-02-22 | Coulter Electronics, Inc. | Apparatus for orienting generally flat particles for sensing |
US4229179A (en) * | 1978-06-30 | 1980-10-21 | Hycel, Inc. | Spectrophotometric measurement in a chemical testing apparatus |
US4577964A (en) * | 1978-09-06 | 1986-03-25 | Ortho Diagnostics, Inc. | Apparatus and method for detecting platelets in whole blood |
US4227814A (en) * | 1979-02-01 | 1980-10-14 | Baxter Travenol Laboratories, Inc. | Optical density detector |
US4444498A (en) * | 1981-02-27 | 1984-04-24 | Bentley Laboratories | Apparatus and method for measuring blood oxygen saturation |
US4522494A (en) * | 1982-07-07 | 1985-06-11 | The United States Of America As Represented By The Department Of Health And Human Services | Non-invasive optical assessment of platelet viability |
US4745279A (en) * | 1986-01-02 | 1988-05-17 | American Hospital Supply Corporation | Hematocrit measuring apparatus |
US4834890A (en) * | 1987-01-30 | 1989-05-30 | Baxter International Inc. | Centrifugation pheresis system |
US4810090A (en) * | 1987-08-24 | 1989-03-07 | Cobe Laboratories, Inc. | Method and apparatus for monitoring blood components |
US5141303A (en) * | 1989-05-08 | 1992-08-25 | Kowa Company Ltd. | Method and apparatus for discriminating eye fundus blood vessels |
US5047652A (en) * | 1990-04-16 | 1991-09-10 | International Paper Company | System for on-line measurement of color, opacity and reflectance of a translucent moving web |
US5372136A (en) * | 1990-10-06 | 1994-12-13 | Noninvasive Medical Technology Corporation | System and method for noninvasive hematocrit monitoring |
US5437598A (en) * | 1994-01-21 | 1995-08-01 | Cobe Laboratories, Inc. | Automation of plasma sequestration |
US5653887A (en) * | 1995-06-07 | 1997-08-05 | Cobe Laboratories, Inc. | Apheresis blood processing method using pictorial displays |
US5769811A (en) * | 1995-10-31 | 1998-06-23 | Haemonetics Corporation | Blood-processing machine system |
US5734464A (en) * | 1996-11-06 | 1998-03-31 | Cobe Laboratories, Inc. | Red blood cell spillover detection technique |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6130743A (en) * | 1999-06-28 | 2000-10-10 | The United States Of America As Represented By The Secretary Of The Navy | Colorimetric red blood cell sensor |
EP1106991A2 (en) * | 1999-12-01 | 2001-06-13 | Fresenius HemoCare GmbH | Method and apparatus for determining particle concentration |
EP1106991A3 (en) * | 1999-12-01 | 2001-12-19 | Fresenius HemoCare GmbH | Method and apparatus for determining particle concentration |
US6627911B2 (en) | 1999-12-01 | 2003-09-30 | Fresenius Hemocare Gmbh | Method for determining a particle concentration and device for implementing the method |
US20050054508A1 (en) * | 2003-09-05 | 2005-03-10 | Ivo Panzani | Control device for the separate collection of blood components in output from a blood centrifugation cell |
US7311849B2 (en) | 2003-09-05 | 2007-12-25 | Sorin Group Italia S.R.L. | Control device for the separate collection of blood components in output from a blood centrifugation cell |
US7407472B2 (en) | 2003-09-11 | 2008-08-05 | Sorin Group Usa, Inc. | Centrifuge apparatus for processing blood |
US20060021952A1 (en) * | 2003-09-11 | 2006-02-02 | Skinkle David W | Apparatus for separating blood components |
US7060018B2 (en) | 2003-09-11 | 2006-06-13 | Cobe Cardiovascular, Inc. | Centrifuge apparatus for processing blood |
EP1605251A1 (en) * | 2004-06-09 | 2005-12-14 | Tyco Electronics Raychem GmbH | Gas sensor arrangement with reduced settling time |
US20060011842A1 (en) * | 2004-06-09 | 2006-01-19 | Rudi Minuth | Gas sensor arrangement with reduced settling time |
US7166842B2 (en) | 2004-06-09 | 2007-01-23 | Tyco Electronics Raychem Gmbh | Gas sensor arrangement with reduced settling time |
US7630076B2 (en) * | 2005-07-26 | 2009-12-08 | University Of Connecticut | Dual-detector systems and methods having utility in biomolecular measurements |
US20070178013A1 (en) * | 2005-07-26 | 2007-08-02 | Kalonia Devendra S | Dual-detector systems and methods having utility in biomolecular measurements |
US8066888B2 (en) | 2007-12-27 | 2011-11-29 | Caridianbct, Inc. | Blood processing apparatus with controlled cell capture chamber trigger |
US20090166297A1 (en) * | 2007-12-27 | 2009-07-02 | Caridianbct, Inc. | Blood Processing Apparatus with Controlled Cell Capture Chamber Trigger |
US8070663B2 (en) | 2008-09-18 | 2011-12-06 | Caridianbct, Inc. | Blood processing apparatus with optical reference control |
US7951059B2 (en) | 2008-09-18 | 2011-05-31 | Caridianbct, Inc. | Blood processing apparatus with optical reference control |
US20110201487A1 (en) * | 2008-09-18 | 2011-08-18 | Caridianbct, Inc. | Blood Processing Apparatus with Optical Reference Control |
US20100065507A1 (en) * | 2008-09-18 | 2010-03-18 | Caridianbct, Inc. | Blood Processing Apparatus with Optical Reference Control |
US20100231893A1 (en) * | 2009-03-10 | 2010-09-16 | Spectra Tracker LLC | Method and device for spectrally detecting hemoglobin |
US8319953B2 (en) * | 2009-03-10 | 2012-11-27 | Spectra Tracker LLC | Method and device for spectrally detecting presence of blood |
US20100267538A1 (en) * | 2009-04-15 | 2010-10-21 | Caridianbct, Inc. | Methods and Apparatus for Hemolysis Detection in Centrifugal Blood Separator |
US8114003B2 (en) | 2009-04-15 | 2012-02-14 | Caridianbct, Inc. | Methods for hemolysis detection in centrifugal blood separator |
US20110082452A1 (en) * | 2009-10-02 | 2011-04-07 | Cardiofocus, Inc. | Cardiac ablation system with automatic safety shut-off feature |
US11666693B2 (en) * | 2016-09-06 | 2023-06-06 | Fresenius Kabi Deutschland | Automated method for leukocyte collection from whole blood |
EP4368219A1 (en) * | 2022-11-08 | 2024-05-15 | Haermonics BV | System for flushing a wound and/or a body cavity, in particular the pericardial cavity |
WO2024100014A1 (en) * | 2022-11-08 | 2024-05-16 | Haermonics Bv | System for flushing a wound and/or a body cavity, in particular the pericardial cavity |
Also Published As
Publication number | Publication date |
---|---|
DE69733198D1 (en) | 2005-06-09 |
US5734464A (en) | 1998-03-31 |
JP2000503406A (en) | 2000-03-21 |
WO1998020345A1 (en) | 1998-05-14 |
JP3698732B2 (en) | 2005-09-21 |
EP0904537A1 (en) | 1999-03-31 |
EP0904537B1 (en) | 2005-05-04 |
DE69733198T2 (en) | 2006-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5936714A (en) | Red blood cell spillover detection technique | |
US4586190A (en) | Blood cell discriminator and counter utilizing transmitted and scattered light | |
KR100219252B1 (en) | Analytical system with very small sample detection means | |
AU610029B2 (en) | Method and apparatus for monitoring blood components | |
KR970007077B1 (en) | Multi-Partial Identification Method Using Light Scattering Technique | |
EP0696731B1 (en) | Cytoanalyzer | |
US4181610A (en) | Blood leak detector suitable for use with artificial kidneys | |
CN107315094B (en) | Coagulation analyzer and coagulation analysis method | |
US5194909A (en) | Apparatus and method for measuring volume and hemoglobin concentration of red blood cells | |
CA1257781A (en) | Integrating device for measuring transmission of light in objects | |
US6525807B1 (en) | Particle analyzing apparatus | |
EP2185927B1 (en) | Device and method for determining the erythrocyte sedimentation rate in a blood sample | |
US4783599A (en) | Particle detector for flowing liquids with the ability to distinguish bubbles via photodiodes disposed 180° apart | |
CA1324894C (en) | Method and apparatus for the identification of particles | |
US20040038413A1 (en) | Method and apparatus for differentiating blood cells using back-scatter | |
US20110235030A1 (en) | Method and device for flow cytometry without sheath fluid | |
CN104075976B (en) | Blood cell analyzer and blood cell analysis method | |
JPS6332352A (en) | Fiber optical device | |
EP0074976A1 (en) | Application of optical fibre probes | |
JPH0792077A (en) | Grain analyzing device | |
JPS6412245A (en) | Particle analyzing device | |
US6995835B2 (en) | Method and apparatus for measuring analytes in blood bags | |
CA2241246C (en) | Red blood cell spillover detection technique | |
Gray et al. | A new method for cell volume measurement based on volume exclusion of a fluorescent dye | |
JPH0792076A (en) | Grain analyzing device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: COBE LABORATORIES, INC., COLORADO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GIBBS, BRUCE W.;REEL/FRAME:009506/0740 Effective date: 19980430 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: GAMBRO, INC., COLORADO Free format text: CHANGE OF NAME;ASSIGNOR:COBE LABORATORIES, INC.;REEL/FRAME:011190/0225 Effective date: 19991221 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGEN Free format text: SECURITY AGREEMENT;ASSIGNOR:GAMBRO, INC.;REEL/FRAME:018552/0717 Effective date: 20061117 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
AS | Assignment |
Owner name: GAMBRO BCT, INC.,COLORADO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GAMBRO, INC.;REEL/FRAME:018787/0264 Effective date: 20061218 Owner name: GAMBRO BCT, INC., COLORADO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GAMBRO, INC.;REEL/FRAME:018787/0264 Effective date: 20061218 |
|
AS | Assignment |
Owner name: CARIDIANBCT, INC., COLORADO Free format text: CHANGE OF NAME;ASSIGNOR:GAMBRO BCT, INC.;REEL/FRAME:021301/0012 Effective date: 20080714 Owner name: CARIDIANBCT, INC.,COLORADO Free format text: CHANGE OF NAME;ASSIGNOR:GAMBRO BCT, INC.;REEL/FRAME:021301/0012 Effective date: 20080714 |
|
FPAY | Fee payment |
Year of fee payment: 12 |
|
AS | Assignment |
Owner name: GAMBRO, INC., COLORADO Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT;REEL/FRAME:026209/0914 Effective date: 20110413 Owner name: CARIDIANBCT, INC., COLORADO Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT;REEL/FRAME:026209/0890 Effective date: 20110413 |
|
AS | Assignment |
Owner name: TERUMO BCT, INC., COLORADO Free format text: CHANGE OF NAME;ASSIGNOR:CARIDIANBCT, INC.;REEL/FRAME:027668/0072 Effective date: 20120106 |